Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer.

Although αEGFR×ULBP6#2 consistently achieved numerically greater tumor growth inhibition than the parental construct, this difference did not reach statistical significance relative to vehicle + NK.

also in 111,027 other papers